BRAFi promote CD4+ and CD8+ T cell infiltration into human metastatic melanoma in addition to increasing expression of melanocyte differentiation antigens by melanoma cells, leading to enhanced recognition by antigen-specific T cells (98–100). This evidence concerns the gene CD8A and melanoma.